Status:
COMPLETED
Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Conditions:
Atrial Fibrillation
Perimitral Flutter
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
This prospective, randomized study aims to compare the impact of ablation of perimitral flutter only versus cardioversion and repeat isolation of pulmonary veins with ablation of additional triggers, ...
Detailed Description
Background: In recent years, catheter ablation has been accepted as the treatment-of-choice for drug-refractory atrial fibrillation (AF). It is centered around isolating pulmonary veins (PVs) and its ...
Eligibility Criteria
Inclusion
- Patients with previous AF ablation presenting with PMFL and recurrent AF
- Age: 18- 75 years
- Willingness and ability to give written informed consent
- Therapeutic INR for at least 4 weeks prior to the procedure
Exclusion
- Reversible causes of AF such as pericarditis and hyperthyroidism
- Documented intra-atrial thrombus, tumor or any other abnormality which prevents easy catheter manipulation
- Enrollment in another clinical study
- Any other terminal illness
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01173796
Start Date
March 1 2010
End Date
September 1 2011
Last Update
July 11 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Cardiac Arrhythmia Research Foundation
Austin, Texas, United States